Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2010
05/12/2010CN101130768B Nucleotide molecule SR1B and application of the same in producing antidiabetic medicament
05/12/2010CN101130090B Application of BRSK2 in producing antidiabetic medicine
05/12/2010CN101058604B FK gene, coding protein and application thereof
05/12/2010CN101049506B DNA preparation of virus M protein of bubble stomatitis, preparation method and application
05/12/2010CN101028522B Function and use of MNSF-beta gene during process of embryo nidation
05/12/2010CN101011582B Medicament for emergency treatment after hydrophobia exposition and emergency therapy at early stage of pathogenesis, and its preparing process
05/11/2010US7714121 Protein for vaccines; immunology response; medical diagnosis; antibody binding to protein
05/11/2010US7713945 Inhibition of dendritic cell function in organ grafts or allogeneic bone marrow transplants by blocking SH2-containing inositol phosphatase (SHIP) expression; preventing immune rejection; reducing antigen presenting cell function; administering interfering RNA specific for SHIP-1 mRNA
05/11/2010US7713942 Drug delivery able crossing cellular membranes; transdermal, electrostatic interaction and a hydrophobic interaction
05/11/2010US7713529 Methods for treating and preventing infectious disease
05/11/2010US7713522 using gutless adenovirus vector; gene therapy; gutless means incapable of expressing any adenovirus antigens; atherosclerosis
05/11/2010CA2527225C Modified recombinant vaccinia viruses and other microorganisms, uses thereof
05/11/2010CA2409674C Glutamic acid decarboxylase (gad) based delivery systems
05/11/2010CA2366914C Enhanced system for construction of adenovirus vectors
05/11/2010CA2362550C Antibody fragment-targeted immunoliposomes for systemic gene delivery
05/11/2010CA2341638C Use of a midkine inhibitor
05/11/2010CA2335105C Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
05/11/2010CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
05/11/2010CA2318492C Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
05/11/2010CA2294709C Compositions and methods for enhancing delivery of therapeutic agents to cells
05/11/2010CA2165297C Myeloid cell leukemia associated gene mcl-1
05/11/2010CA2122365C Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
05/06/2010WO2010051534A2 Method for apcdd1 mediated regulation of hair growth and pigmentation and mutants thereof
05/06/2010WO2010050997A1 Method for adenoviral vector synthesis
05/06/2010WO2010050802A2 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53.
05/06/2010WO2010050586A1 Method for enhancing expression of recombinant protein
05/06/2010WO2010050585A1 Vector for treating alzheimer's disease
05/06/2010WO2010050584A1 Method for selectively controlling function of helper t cell
05/06/2010WO2010050328A1 Tumor metastasis inhibitor
05/06/2010WO2010049590A2 A new pharmaceutical product
05/06/2010WO2009158284A9 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
05/06/2010WO2009086156A3 Mir-10 regulated genes and pathways as targets for therapeutic intervention
05/06/2010US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same
05/06/2010US20100113567 Recombinant VSV For The Treatment of Tumor Cells
05/06/2010US20100113561 Microrna molecules
05/06/2010US20100113559 Chitosan Based Polymer Conjugate and a Method for Producing the Same
05/06/2010US20100113361 Anti-ige vaccines
05/06/2010US20100113335 Compositions and methods for treatement of cancer
05/06/2010US20100112689 Method of obtaining viable human cells, including hepatic stem/progenitor cells
05/06/2010US20100112685 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities
05/06/2010US20100112640 Polynucleotide
05/06/2010US20100112044 Method and apparatus for encapsulating pharmaceutical and nutriceutical bioactives for intestinal delivery
05/06/2010US20100112043 Transpulmonary liposome for controlling drug arrival
05/06/2010US20100112042 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
05/06/2010US20100111991 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
05/06/2010US20100111937 Modulation of Toll-Like Receptor 5 Expression by Antisense Oligonucleotides
05/06/2010US20100111936 Modulation of Toll-Like Receptor 4 Expression by Antisense Oligonucleotides
05/06/2010US20100111935 Modulation of Toll-Like Receptor 2 Expression By Antisense Oligonucleotides
05/06/2010US20100111924 Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage Site
05/06/2010US20100111869 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
05/06/2010US20100111855 Frozen compositions and methods for piercing a substrate
05/06/2010CA2741793A1 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53
05/06/2010CA2741664A1 Method for selective control of helper t cell function
05/05/2010EP2182005A1 A gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof
05/05/2010EP2181595A1 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
05/05/2010EP1845162B1 DNA sequences having anti-repressor activity
05/05/2010EP1842919B1 DNA sequences having anti-repressor activity
05/05/2010EP1829971B1 DNA sequences having anti-repressor activity
05/05/2010EP1806407B1 DNA sequences having anti-repressor activity
05/05/2010EP1694851B1 Viral vectors controlled by a gene switch
05/05/2010EP1648520B1 Compounds and methods for downregulating the effects of tgf-beta
05/05/2010EP1414486B1 Use of glp-2 in combination with another therapeutic agent in bone-related disorders
05/05/2010EP1232157B1 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
05/05/2010EP1060261B1 Poly zinc finger proteins with improved linkers
05/05/2010EP0935648B1 Improved adenovirus vectors
05/05/2010CN1981044B Lipid encapsulated interfering RNA
05/05/2010CN1708587B Recombinant MVA strains as potential vaccines against p. falciparum malaria
05/05/2010CN1548537B Vaccine preparing process and antitumor vaccine
05/05/2010CN1446261B Modified cytokines for use in cancer therapy
05/05/2010CN1420924B Recombinant human alpha-L-iduronidase, method for producing and purifying same and method for treating disorders including deficiency thereof
05/05/2010CN101701219A cDNA for encoding rabbit hepatocyte growth factor and expression vector and application thereof
05/04/2010US7709628 Modulation of STAT5 expression
05/04/2010US7709621 Vectors with modified protease-dependent tropism
05/04/2010US7709617 Derivatized with a glycerol linker, 2'-deoxy-7-deazaguanosine and arabinoguanosine; immunomer is self-complementary; anticarcinogenic, antiinflammatory, antiallergen, antihistamine, and bronchodilator agents; asthma, skin disorders
05/04/2010US7709464 Drud delivery; prolonging the time a pharmaceutical drug circulates in the blood of a subject by using a liposome containing the inventive compound as a carrier
05/04/2010US7709457 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol
05/04/2010US7709455 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist
05/04/2010US7709452 Pharmaceutical composition which improves in vivo gene transfer
05/04/2010US7709450 Stimulation of vascularization with VEGF-B-186
05/04/2010US7709270 Using platelete derived growth factor as tool in detection of modulators for prevention and treatment of cell proliferative disorders
05/04/2010US7709220 Methods of monitoring treatment of BAFF-R related disease
05/04/2010US7709216 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death
05/04/2010US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders
05/04/2010US7709211 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
05/04/2010US7709205 Antiproliferative agents; antiapoptosis; drug screening; blot analysis; immunohistochemistry; RNA interference; fluorescence in situ hybridization; determining prognosis in a subject with breast cancer, comprising determining overexpression of 14-3-3 zeta mRNA
05/04/2010US7709202 Molecular characteristics of non-small cell lung cancer
05/04/2010US7709032 Lotus extract and lactic acid bacterium active ingredients exhibit synergistic amelioration or treatment of allergic diseases including hay fever, bronchial asthma and dermatitis, such as atopic dermatitis; foods; reduced immunoglobulins (IgE);interleukin-4 inhibitor; tumor necrosis factor inhibitors
05/04/2010US7709008 An recombinant serine-aspartate repeat (Sdr) protein from Staphylococcus epidermidis which is cell-wall associated, wherein the protein comprises the amino acid sequence 10-1742 of SEQ ID NO: 4.; multicomponent vaccines; coating polymericbiomaterials; catheters; prosthetics; nucleic acid probes
05/04/2010US7709000 Using MG1(mucin) specific immunoglobulins to target therapeutic agents to tumor cells
05/04/2010US7708996 Tumor necrosis factor receptor specific immunoglobulins for use in treatment and prevention of cancers, autoimmune, viral, inflammatory, graft vs host and nervous system disorders
05/04/2010US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents
05/04/2010US7708986 Targeted vectors for cancer immunotherapy
05/04/2010US7708977 Method for diagnosis and treatment of vascular disease
05/04/2010CA2448863C Increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition
05/04/2010CA2412880C Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product
05/04/2010CA2378438C Methods for preparation of lipid-encapsulated therapeutic agents
05/04/2010CA2347178C Methods of inhibiting smooth muscle cell proliferation and preventing restenosis with a vector expressing rb2/p130
05/04/2010CA2223503C Transferrin receptor genes
05/04/2010CA2089376C Sugar modified oligonucleotides that detect and modulate gene expression
04/2010
04/29/2010WO2010048585A2 Oligomeric compounds and methods
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 870